A study in South Africa tested the feasibility of home-based influenza testing for individuals showing respiratory symptoms, collecting swabs and vaccination data from participants aged 18 and older.
Out of 1456 samples, 5% tested positive for influenza, while 27% were positive for SARS-CoV-2; the overall vaccine effectiveness for influenza was determined to be 26%.
The service was well-received, with 97% of participants willing to use it again, suggesting that home swabbing could be a practical option for respiratory surveillance in the future.*